The long term objective of this project is a combined biochemical and genetic analysis of the hormonal regulation of cell membrane characteristics relevant to neoplasia. These studies have focused on the glucocorticoid and cyclic nucleotide regulation of the serine protease, tissue-type plasminogen activator (tPA), in HTC rat hepatoma cells in culture. The synthetic glucocorticoid dexamethasone rapidly inhibits tPA activity, whereas cyclic nucleotides dramatically stimulate tPA activity; paradoxically, dexamethasone enhances this stimulation. We have demonstrated that the glucocorticoid inhibition of tPA activity is secondary to the induction of a specific PA-inhibitor, PAI-1. We have purified and characterized the HTC PAI-1, and have cloned and characterized the cDNA for human endothelial cell PAI-1. The objective of the current proposal is to extend our studies on the hormonal regulation of tPA and PAI-1 to the molecular level. Techniques for the measurement of PA and PAI activity, antigen and mRNA are available and in use in our laboratory. We plan to compare the glucocorticoid and cyclic nucleotide regulation of tPA and PAI-1 in primary rat hepatocyte cultures with that in HTC rat hepatoma cells, examining the regulation of activity, antigen and mRNA levels for these two proteins and the mechanisms by which these levels are controlled. We will clone and characterize the cDNA and gemonic DNA for rat PAI-1, and clone and characterize the putative 5' regulatory regions of the rat tPA gene. Finally, we will analyze the nucleotide sequence requirements for the glucocorticoid and cyclic nucleotide regulation of rat tPA and PAI-1 gene expression with particular emphasis on combinatorial regulation by these agents. These studies will utilize DNAse hypersensitivity assays, nuclease protection techniques, and construction of chimeric genes containing wild-type and mutant regulatory elements of the tPA and PAI-1 genes and characterization of their hormonal regulation in transfected cells. Limited proteolysis mediated by the plasminogen activator- plasmin cascade plays a significant role in the behavior of transformed cells and in many normal processes. These studies should increase our understanding of the hormonal regulation of this important cell membrane property and of the biology of neoplastic cells.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37CA022729-13
Application #
3481945
Study Section
Cellular Biology and Physiology Subcommittee 1 (CBY)
Project Start
1978-01-01
Project End
1992-12-31
Budget Start
1990-01-01
Budget End
1990-12-31
Support Year
13
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Heaton, Joanne H; Dlakic, Wendy M; Gelehrter, Thomas D (2003) Posttranscriptional regulation of PAI-1 gene expression. Thromb Haemost 89:959-66
Heaton, J H; Dlakic, W M; Dlakic, M et al. (2001) Identification and cDNA cloning of a novel RNA-binding protein that interacts with the cyclic nucleotide-responsive sequence in the Type-1 plasminogen activator inhibitor mRNA. J Biol Chem 276:3341-7
White, L A; Bruzdzinski, C; Kutz, S M et al. (2000) Growth state-dependent binding of USF-1 to a proximal promoter E box element in the rat plasminogen activator inhibitor type 1 gene. Exp Cell Res 260:127-35
Tillmann-Bogush, M; Heaton, J H; Gelehrter, T D (1999) Cyclic nucleotide regulation of PAI-1 mRNA stability. Identification of cytosolic proteins that interact with an a-rich sequence. J Biol Chem 274:1172-9
Seki, T; Healy, A M; Fletcher, D S et al. (1999) IL-1beta mediates induction of hepatic type 1 plasminogen activator inhibitor in response to local tissue injury. Am J Physiol 277:G801-9
Song, C Z; Tian, X; Gelehrter, T D (1999) Glucocorticoid receptor inhibits transforming growth factor-beta signaling by directly targeting the transcriptional activation function of Smad3. Proc Natl Acad Sci U S A 96:11776-81
Heaton, J H; Tillmann-Bogush, M; Leff, N S et al. (1998) Cyclic nucleotide regulation of type-1 plasminogen activator-inhibitor mRNA stability in rat hepatoma cells. Identification of cis-acting sequences. J Biol Chem 273:14261-8
Song, C Z; Siok, T E; Gelehrter, T D (1998) Smad4/DPC4 and Smad3 mediate transforming growth factor-beta (TGF-beta) signaling through direct binding to a novel TGF-beta-responsive element in the human plasminogen activator inhibitor-1 promoter. J Biol Chem 273:29287-90
Seki, T; Imai, H; Uno, S et al. (1996) Production of tissue-type plasminogen activator (t-PA) and type-1 plasminogen activator inhibitor (PAI-1) in mildly cirrhotic rat liver. Thromb Haemost 75:801-7
Thornton, A J; Bruzdzinski, C J; Raper, S E et al. (1994) Plasminogen activator inhibitor-1 is an immediate early response gene in regenerating rat liver. Cancer Res 54:1337-43

Showing the most recent 10 out of 34 publications